Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
-
Cummins admits changes may be made after loss to South Africa
-
China state TV does not air first La Liga games since Mbappe furore
-
Atletico beat Levante to move top above Barcelona
-
Thousands turn up for France protests amid tight security
-
Chelsea defeat pushes Carrick closer to Man Utd exit
-
Our part of Mbappe, China issue over: Real Madrid's Mourinho
-
Pogacar 'happy to be alive' after difficult Vuelta crash recovery
-
Evacuees from Russian-occupied Oleshky arrive in Ukraine
-
South Africa beat Australia by 176 runs in third Test to win series
-
Kamindu hits maiden ODI ton as Sri Lanka set Pakistan 326 in final
-
Evacuees from Russian-occupied Oleshky expected in Ukraine
-
Aston Villa to take legal action against pundit Carragher
-
UK PM 'open' to slavery apology but not reparations
-
West Indies crush Bangladesh by eight wickets in first Test
-
Kimono-clad pets blessed at Japan festival lacking enough kids
-
France on alert as Halloween protests raise risk of violence
-
Hakimi bags hat-trick as PSG rip Le Havre to pieces
-
Abhishek Sharma: Indian cricket's 'new-generation superstar'
-
In-form Fernandez sets up Tokyo final against Russia's Shnaider
-
Marquez stretches MotoGP championship lead after Martin pulls out
-
Scam centres relocated from Cambodia operate in Madagascar
-
In-form Fernandez reaches Tokyo final
-
Marc Marquez on front row at Malaysian MotoGP as Martin ruled out
-
James, Maxey fuel 76ers over Knicks in NBA Cup thriller
-
Injured Martin out of Malaysian MotoGP in big title blow
-
High-speed, high-risk Route du Rhum yacht race sets off Sunday
-
US, S.Korea, Japan vow 'complete' N.Korea denuclearization
-
Fears of violence as France braces for Halloween protests
-
Nations commit to get nature goals back on track
-
OKC's Holmgren to miss at least eight weeks as Thunder injury woes deepen
-
US oil companies aim to squeeze more out of refineries
-
'Not very smart' - Verstappen slams Red Bull stable-mate after clash
-
How to Repurpose Old Furniture into New Treasures
-
Leclerc quickest in Mexico GP practice
-
Trump admin approves potential Patriot missiles sale to Ukraine
-
Polish riot police deployed as deposed court chief sets off crisis
-
Sun Goddess wins at Breeders' Cup, O'Brien leads Baffert
-
Young Canadians focus on mental health at key climate trial
-
Nations agree push to get nature goals on track
-
'Breath of fresh air' truce brings hope to Ukraine's ravaged Kherson
-
Leclerc shows practice pace as Antonelli prowls in Mexico
-
British king reflects on colonial atrocities in Guyana
-
Trump, Milei under pressure to explain Bolsonaro flight from Brazil
-
Nations agree crucial texts in overtime at UN nature summit
-
Hakimi bags hat-trick as Paris Saint-Germain rip Le Havre to pieces
-
NBA Trail Blazers lose guard Morant for four weeks
-
Polish riot police deployed after court chief suspended
-
UN nature summit in extra time as nations grapple for deal
-
Emery's focus fully on Fulham despite Barcelona tie
-
Complaints upheld against Swiss TV commentary on Israeli bobsleigher
Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
NEW YORK CITY, NY / ACCESS Newswire / April 22, 2026 / Emerging Growth Research today announced the release of a Flash Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating its Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's recent share price of $3.65 as of April 21, 2026.
The Flash Report provides an update following recent share price volatility tied to a secondary share transaction, while reaffirming the Company's long-term growth outlook and underlying fundamentals.
Key Highlights from the Flash Report:
Secondary Share Transaction Misinterpreted by Market: SBC recently completed a secondary share issuance reflecting approximately a 3% reduction in the founder's ownership stake. Importantly, the transaction did not result in shareholder dilution, though shares declined following the offering due to the discounted pricing.
Founder Alignment Remains Strong: Despite the transaction, the founder/CEO continues to hold a significant majority stake in the Company, reinforcing long-term alignment with shareholders.
Improved Share Liquidity: The increase in public float-potentially up to 20%-is expected to enhance trading liquidity and may support broader institutional participation.
Potential Index Inclusion Catalyst: Increased float-adjusted market capitalization could improve SBC's eligibility for inclusion in the Russell Index.
Growth Recovery Expected in 2026: Following pricing-related revenue pressure in 2025, management continues to target a return to revenue growth during 2026.
Strategic Expansion Initiatives: SBC is pursuing international M&A opportunities and new initiatives in AI-driven operations and longevity-focused services.
Attractive Valuation: The recent share price pullback has created a disconnect between valuation and fundamentals, supported by a strong net cash position.
For a copy of the full Flash Report, please visit:
https://emerginggrowth.com/wp-content/uploads/2026/04/SBC_Flash-Report_4.22.26.pdf
Or
https://www.EmergingGrowth.com/profile/sbc/ (on the right side of the page as you scroll down)
About SBC Medical Group
SBC Medical Group Holdings, Inc. provides management services to cosmetic treatment centers through a franchise model, operating across Japan, Southeast Asia, and the United States.
About Emerging Growth Research
Emerging Growth Research is an independent equity research firm providing institutional-quality analysis on emerging growth companies.
Contact:
Emerging Growth Research
[email protected]
www.EmergingGrowth.com
Forward-Looking Statements
This press release contains forward-looking statements concerning business operations, financial performance, and future expectations of SBC Medical Group Holdings, Inc. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
SOURCE: SBC Medical Group Holdings Incorporated
View the original press release on ACCESS Newswire
P.M.Smith--AMWN
